T1	Participants 206 273	patients and in dogs with experimentally induced heart failure (HF)
T2	Participants 616 739	Six dogs with microembolizations-induced HF and 9 HF patients underwent CCM leads and generator (OPTIMIZER II) implantation
T3	Participants 1162 1166	dogs
